Strategic Initiative

Slingshot members are tracking this corporate initiative:

Roche (RHHBY) and Halozyme (HALO) Sign Collaboration Agreement to Evaluate PEGPH20 and Tecentriq in Eight Types of Tumors

Source Link:: http://www.halozyme.com/investors/news-releases/news-release-details/2016/Halozyme-Announces-Broad-Clinical-Collaboration-Agreement-To-Evaluate-PEGPH20-And-Tecentriq-In-Up-To-Eight-Tumor-Types/default.aspx

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies

Importance

High

Medium

Low

Impact on Stocks

100%

100%

Strategic Initiative Date

Announcement Date:

Nov 10, 2016

Projected Implementation:

Q1, 2017

Relevance Tracked Until:

Q1, 2019

Related Projects

Related Keywords Collaboration Agreement, Pegph20, Tecentriq, Tumors